Evidence map›Paper›PMID 42028156›Full record

ReviewInternational journal of chronic obstructive pulmonary disease2026

Beyond the Lungs: A Narrative Review of Cardiopulmonary Risk Reduction and Management Perspectives in Thai COPD Patients.

Kittipong Maneechotesuwan, Siwasak Juthong, Piamlarp Sangsayunh, Pailin Ratanawatkul, Prin Vathesatogkit, Teerapat Yingchoncharoen, Srisakul Chirakarnjanakorn, Chee Kuan Wong, Thitiwat Sriprasart

Abstract readReview
In one paragraph

Review in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kittipong Maneechotesuwan *Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0001-5940-7436
Siwasak Juthong *Respiratory and Respiratory Critical Care Unit, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Piamlarp SangsayunhPulmonary Department, Central Chest Institute of Thailand, Nonthaburi, Thailand.
Pailin RatanawatkulDepartment of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Prin VathesatogkitDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Teerapat YingchoncharoenDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Srisakul ChirakarnjanakornDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Chee Kuan WongDepartment of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Thitiwat SriprasartDepartment of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and results in chronic lung damage and airway obstruction, significantly impacting individual health. Apart from increased all-cause mortality, COPD exacerbations are associated with higher rates of cardiovascular (CV) events-driven by shared risk factors and pathophysiological mechanisms-with peaks in the first 30 days of post-exacerbation. Therefore, cardiopulmonary risk management is essential during this vulnerable period. This narrative review was developed through an evaluation of clinical studies, guideline recommendations and Thailand-specific data to outline cardiopulmonary linkage in COPD and propose post-COPD exacerbation management. Patient management strategies include optimized pharmacological and non-pharmacological therapies, integrated cardiopulmonary care and CV risk assessment to reduce exacerbations, mortality and CV-related events, particularly in COPD patients with established or suspected CV diseases. Furthermore, implementation of these concepts should emphasize strengthening multidisciplinary awareness among pulmonary and cardiology through professional education, continuing-development activities and integration of collaborative care into national guidelines.

Indexed as

Cardiovascular DiseasesLungPulmonary Disease, Chronic ObstructiveRisk Reduction BehaviorDisease ProgressionHeart Disease Risk FactorsHumansPractice Guidelines as TopicRisk AssessmentRisk FactorsThailandTreatment Outcomecardiopulmonary riskcardiovascular riskCOPD exacerbationCOPD managementdischarge planning

Identifiers

PMID42028156
PMCPMC13100312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.